News Feed Opinion Career Insight Dialogues Blog Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
July, 2024
July 2024
M T W T F S S
1234567
891011121314
15161718192021
22232425262728
293031  
Yige Bao: Our data from the high-risk UTUC nephron-sparing trial has been accepted at ESMO 2024
Jul 24, 2024, 01:00

Yige Bao: Our data from the high-risk UTUC nephron-sparing trial has been accepted at ESMO 2024

Yige Bao, Oncological Urologist and Microbiome researcher in West China Hospital, shared a post on X:

“Exciting news! Our data from the high-risk UTUC nephron-sparing trial has been accepted at ESMO 2024 (European Society for Medical Oncology Congress 2024)! Demonstrating the potential to preserve kidneys in carefully selected high-risk UTUC patients.”

Source: Yige Bao/X

cancer ESMO 2024 European Society for Medical Oncology kidney cancer OncoDaily Oncology UTUC nephron-sparing trial UTUC patients West China Hospital Yige Bao
Blog
Jul 24, 2024, 01:55
Muktar Bagudo Abubakar: Amazing learning platform that seeks to stimulate affirmative action in the cancer space
Blog
Jul 24, 2024, 01:38
Michele Kenner: Renowned specialists who are committed to achieving exceptional patient outcomes
Blog
Jul 24, 2024, 01:24
Mel Mann: I will be speaking at this year’s Leukemia and Lymphoma Society’s Southern Blood Cancer Conference
Blog
Jul 24, 2024, 01:02
Sofia Merajver: Meeting families with ALK is an incredible highlight of my whole career
Blog
Jul 24, 2024, 01:01
Petros Grivas: Uromigos cup came to Greek home
Blog
Jul 24, 2024, 01:01
Timothée Olivier: Interim data of early phase results from novel RAS inhibitor in pancreatic cancer
Blog
Jul 24, 2024, 01:01
Webinar on regulatory submission writing for NDA success - ICON plc
Blog
Jul 24, 2024, 01:00
Chiara Corti: Over 1,900 downloads for our educational chapter on systemic therapy in breast cancer
Blog
Jul 24, 2024, 01:00
Another incredible session with the brain tumor families at the Richi House - Richi Childhood Cancer Foundation
Blog
Jul 24, 2024, 01:00
Yige Bao: Our data from the high-risk UTUC nephron-sparing trial has been accepted at ESMO 2024
Blog
Jul 24, 2024, 01:00
Cristiane Bergerot: Honored to be at ANZUP24
Insight
Jul 24, 2024, 00:59
Luca Licata: The fate of immunotherapy trials in breast cancer